Skip to main content
. 2021 Jan 19;35(4):938–947. doi: 10.1111/jdv.17002

Figure 5.

Figure 5

Proportion of patients achieving Children’s Dermatology Life Quality Index 0 or 1 score (LOCF analysis). *Patients on PBO completed treatment at Week 12. CDLQI, Children’s Dermatology Life Quality Index; ETN, etanercept; HD, high dose; LD, low dose; LOCF, last observation carried forward; m, number of patients available for evaluation; n, number of patients; SEC, secukinumab.